Volume 10, Issue 5, Pages (November 2009)

Slides:



Advertisements
Similar presentations
Volume 14, Issue 2, Pages (August 2011)
Advertisements

Volume 10, Issue 4, Pages (October 2009)
Volume 14, Issue 6, Pages (December 2011)
Volume 9, Issue 3, Pages (March 2009)
Volume 14, Issue 4, Pages (October 2011)
Won Hee Choi, Jiyun Ahn, Chang Hwa Jung, Jung Sook Seo, Tae Youl Ha 
Volume 6, Issue 6, Pages (December 2007)
Won Hee Choi, Jiyun Ahn, Chang Hwa Jung, Jung Sook Seo, Tae Youl Ha 
Volume 8, Issue 4, Pages (October 2008)
Volume 20, Issue 4, Pages (October 2014)
Volume 3, Issue 5, Pages (May 2006)
Volume 16, Issue 10, Pages (September 2016)
Volume 20, Issue 4, Pages (October 2014)
Ling Yang, Ping Li, Suneng Fu, Ediz S. Calay, Gökhan S. Hotamisligil 
Irs1 Serine 307 Promotes Insulin Sensitivity in Mice
Volume 11, Issue 5, Pages (May 2010)
Grzegorz Sumara, Olga Sumara, Jason K. Kim, Gerard Karsenty 
Volume 6, Issue 3, Pages (September 2007)
Volume 18, Issue 2, Pages (August 2013)
Volume 15, Issue 2, Pages (February 2012)
Volume 21, Issue 11, Pages (December 2017)
Volume 17, Issue 5, Pages (May 2013)
Selective versus Total Insulin Resistance: A Pathogenic Paradox
Volume 15, Issue 5, Pages (May 2012)
Volume 9, Issue 6, Pages (June 2009)
Volume 23, Issue 4, Pages (April 2016)
Volume 25, Issue 2, Pages (February 2017)
Volume 20, Issue 1, Pages (July 2014)
Insulin Signaling in α Cells Modulates Glucagon Secretion In Vivo
Volume 14, Issue 2, Pages (August 2011)
Volume 20, Issue 1, Pages (July 2014)
Volume 16, Issue 7, Pages (August 2016)
Heat Shock Transcription Factor 1 Is a Key Determinant of HCC Development by Regulating Hepatic Steatosis and Metabolic Syndrome  Xiongjie Jin, Demetrius.
Volume 23, Issue 6, Pages (June 2016)
Volume 16, Issue 4, Pages (October 2012)
Volume 9, Issue 5, Pages (May 2009)
Volume 17, Issue 8, Pages (November 2016)
Volume 6, Issue 4, Pages (October 2007)
Volume 19, Issue 2, Pages (February 2014)
Volume 10, Issue 1, Pages (July 2009)
Volume 8, Issue 4, Pages (October 2008)
Volume 25, Issue 4, Pages e4 (April 2017)
Volume 14, Issue 1, Pages (July 2011)
Volume 16, Issue 4, Pages (October 2012)
Volume 5, Issue 5, Pages (May 2007)
Volume 1, Issue 4, Pages (April 2005)
Volume 22, Issue 2, Pages (August 2015)
Jieun Lee, Joseph Choi, Susanna Scafidi, Michael J. Wolfgang 
Volume 6, Issue 1, Pages (July 2007)
Volume 6, Issue 3, Pages (September 2007)
Volume 14, Issue 4, Pages (October 2011)
Volume 3, Issue 2, Pages (February 2006)
Volume 10, Issue 6, Pages (December 2009)
Prevention of Steatosis by Hepatic JNK1
Volume 15, Issue 6, Pages (June 2012)
High-Fat Diet Triggers Inflammation-Induced Cleavage of SIRT1 in Adipose Tissue To Promote Metabolic Dysfunction  Angeliki Chalkiadaki, Leonard Guarente 
Volume 8, Issue 5, Pages (November 2008)
Volume 14, Issue 2, Pages (August 2011)
Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice  Decheng Ren, Minghua Li, Chaojun Duan, Liangyou.
Volume 7, Issue 6, Pages (June 2008)
Volume 22, Issue 2, Pages (August 2015)
Volume 20, Issue 4, Pages (October 2014)
Volume 6, Issue 4, Pages (October 2007)
Volume 4, Issue 5, Pages (November 2006)
Volume 18, Issue 1, Pages (July 2013)
Of Mice and Men: Not ExAKTly the Same?
Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice  Jun Yoshino, Kathryn F. Mills,
The GCN2 eIF2α Kinase Regulates Fatty-Acid Homeostasis in the Liver during Deprivation of an Essential Amino Acid  Feifan Guo, Douglas R. Cavener  Cell.
Volume 16, Issue 3, Pages (September 2012)
Regulation of Gluconeogenesis by Krüppel-like Factor 15
Presentation transcript:

Volume 10, Issue 5, Pages 405-418 (November 2009) Akt2 Is Required for Hepatic Lipid Accumulation in Models of Insulin Resistance  Karla F. Leavens, Rachael M. Easton, Gerald I. Shulman, Stephen F. Previs, Morris J. Birnbaum  Cell Metabolism  Volume 10, Issue 5, Pages 405-418 (November 2009) DOI: 10.1016/j.cmet.2009.10.004 Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 1 Deletion of Akt2 in Lepob/ob Mice Results in Decreased Hepatic Triglycerides and De Novo Lipogenesis (A and B) Body weight (A) or liver weight (B) of 12-week-old fed male mice. (C and D) Hepatic triglyceride levels of 12-week-old fed (C) or overnight fasted (D) male mice. (E and F) Blood glucose (E) and insulin (F) levels in 8-week-old overnight fasted male mice. (G) De novo lipogenesis. 12-week-old male mice were injected with D2O after a 5 hr fast and sacrificed after 3 hr, and liver was removed and analyzed for palmitate by GC/MS. All values are expressed as mean ± SEM. n = 5–6. ∗p < 0.05 versus Lep+/+ Akt2+/+, and ∗∗p < 0.05 versus Lepob/ob Akt2+/+ by one-way ANOVA using Newman-Keuls posttest. Cell Metabolism 2009 10, 405-418DOI: (10.1016/j.cmet.2009.10.004) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 2 Lepob/ob AFP;Akt2lox/lox Mice Have Decreased Hepatic Triglyceride Levels that Correlate with a Decrease in De Novo Lipogenesis (A and B) Body weight (A) or liver weight (B) of 12-week-old fed male mice. n = 6–8. (C and D) Blood glucose (C) and insulin (D) levels in 8-week-old overnight fasted male mice. n = 6–9. (E and F) Hepatic triglyceride levels of 12-week-old fed (E) or overnight fasted (F) male mice. n = 6–9. (G) Hepatic long-chain fatty acid CoA (LLCoA) concentrations from 12-week-old overnight fasted male mice. n = 3–4. (H) De novo lipogenesis measured as in Figure 1. n = 5–6. All values are expressed as mean ± SEM. ∗p < 0.05 versus Lep+/+ Akt2lox/lox, and ∗∗p < 0.05 versus Lepob/ob Akt2lox/lox by one-way ANOVA using Newman-Keuls posttest. Cell Metabolism 2009 10, 405-418DOI: (10.1016/j.cmet.2009.10.004) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 3 Hepatic Gene Expression in Lepob/ob AFP;Akt2lox/lox Mice Hepatic gene expression as measured by real-time PCR of 12-week-old fed male mice. Data are presented as mRNA expression relative to that of TATA-binding protein (TBP) and normalized to expression in Akt2lox/lox, which is set to 1.0 using the ddCT method. All values are expressed as mean ± SEM. n = 6. ∗p < 0.05 versus Lep+/+ Akt2lox/lox, and ∗∗p < 0.05 versus Lepob/ob Akt2lox/lox by one-way ANOVA using Newman-Keuls posttest. Cell Metabolism 2009 10, 405-418DOI: (10.1016/j.cmet.2009.10.004) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 4 Akt2−/− Mice Have Decreased Hepatic Triglyceride Levels after 4 Months on Surwit HFD (A–F) Male mice were started on Surwit HFD at ∼5 weeks of age and sacrificed after either 1 or 4 months along with age-matched chow controls. Shown are body weight (A) and liver weight (B); hepatic triglyceride levels of fed (C) or overnight fasted (D) mice; and blood glucose (E) and insulin (F) levels from overnight fasted mice after 4 months on HFD. Values are expressed as mean ± SEM. n = 5–9. ∗p < 0.05 by one-way ANOVA using Newman-Keuls posttest. Cell Metabolism 2009 10, 405-418DOI: (10.1016/j.cmet.2009.10.004) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 5 AFP;Akt2lox/lox Mice on Surwit HFD Have Decreased Hepatic Triglyceride Levels but Do Not Exhibit Changes in De Novo Lipogenesis (A–E) Male mice were started on Surwit HFD at ∼5 weeks of age and sacrificed after either 1 or 4 months along with age-matched chow controls. Shown are body weight (A) and liver weight (B); blood glucose (C) and insulin (D) levels from overnight fasted mice after 4 months on HFD; and hepatic triglyceride levels of fed mice (E). n = 5–9. ∗p < 0.05 versus Akt2lox/lox chow, and ∗∗p < 0.05 versus Akt2lox/lox HFD by one-way ANOVA using Newman-Keuls posttest. (F) Hepatic long-chain fatty acyl CoA (LLCoA) concentrations from overnight fasted male mice after 1 month on Surwit HFD. n = 4. ∗p < 0.05 versus Akt2lox/lox chow by two-way ANOVA using Bonferroni posttest. (G) De novo lipogenesis. Lipogenesis was assayed in male mice after 4 months on Surwit HFD as in Figure 1. n = 5. ∗p < 0.05 versus Akt2lox/lox chow by one-way ANOVA using Newman-Keuls posttest. All values are expressed as mean ± SEM. Cell Metabolism 2009 10, 405-418DOI: (10.1016/j.cmet.2009.10.004) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 6 Hepatic Gene Expression in AFP;Akt2lox/lox Mice on Surwit HFD Hepatic gene expression as measured by real-time PCR of male mice after 1 month on Surwit HFD or age-matched chow-fed controls sacrificed under fed conditions. Data are presented as mRNA expression relative to that of TBP and normalized to expression in Akt2lox/lox chow-fed, which is set to 1.0 using the ddCT method. All values are expressed as mean ± SEM. n = 6. ∗p < 0.05 versus Akt2lox/lox chow, and ∗∗p < 0.05 versus Akt2lox/lox HFD by one-way ANOVA using Newman-Keuls posttest. Cell Metabolism 2009 10, 405-418DOI: (10.1016/j.cmet.2009.10.004) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 7 AFP;Akt2lox/lox Mice on Lard HFD Have Decreased Hepatic Triglyceride Levels and SREBP1c Expression Male mice were started on lard HFD at ∼6 weeks of age and sacrificed after 1 month on diet under fed conditions along with age-matched chow-fed controls. (A) Hepatic triglycerides. (B) Hepatic gene expression as measured by real-time PCR. Data are presented as mRNA expression relative to that of TBP and normalized to expression in Akt2lox/lox chow fed, which is set to 1.0 using the ddCT method. All values are expressed as mean ± SEM. n = 5–6. ∗p < 0.05 versus Akt2lox/lox chow, and ∗∗p < 0.05 versus Akt2lox/lox HFD by one-way ANOVA using Newman-Keuls posttest. (C) Western blot of phospho-Akt (p473 and p308) and downstream signaling targets in hepatic lysates from Akt2lox/lox and AFP;Akt2lox/lox mice. 8-week-old male mice were fasted overnight and IP injected with either saline or 1 U/kg insulin and then sacrificed after 20 min. Each lane represents an individual mouse. Loading controls are included when blots from different gels were used for phosphoprotein and total protein, though the same protein extracts were used. The arrow indicates Akt2, as there is a slightly more mobile nonspecific band. Cell Metabolism 2009 10, 405-418DOI: (10.1016/j.cmet.2009.10.004) Copyright © 2009 Elsevier Inc. Terms and Conditions